AlphAIalphai — Financial news for AI agents
SEC EDGARAUG 52 min read$OKLO

Cochran Caroline sold $3.3M of OKLO (indirect holdings)

Cochran Caroline (Co-Founder, COO) sold 80,000 indirectly-held shares of Oklo Inc. (OKLO) at an average of $40.63 ($38.55–$41.68, $3.25M total) across 5 trades on 2026-08-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Cochran Caroline
Published Aug 5, 2026, 8:06 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 8:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$OKLO
Neutral
high confidence
Mentioned
$OKLO
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OKLONeutralLow
01

Why it matters

The newest fact is the specific insider sale size, share count, price range, and that it was executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may monitor for follow-on insider activity, but this filing alone does not change Oklo’s fundamentals.

03

What to watch

The sale is indirect and explicitly pre-arranged under Rule 10b5-1, which reduces interpretability as a discretionary view on the stock.

Relevance 5/10Novelty 5/10Timing: filed Aug. 5, transaction dated Aug. 3

Background

The article is an SEC Form 4 insider transaction disclosure for Oklo Inc.

Company-level read

Ticker impact

$OKLONeutralHigh confidence
Context

Oklo co-founder and COO Caroline Cochran sold $3.25M of OKLO shares via a 10b5-1 plan across 80,000 shares on Aug. 3.

Expected impact

Likely limited, with any impact more sentiment-driven than fundamental.

Evidence & confidence

The filing is a Form 4 insider transaction with a pre-arranged 10b5-1 plan; it does not include new operating, regulatory, or financial guidance.

Market effects

Sector

Minimal, since it is company-specific insider selling without sector-wide catalyst.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

A 10b5-1 sale can be routine and may not signal bearish fundamentals; traders may overreact to the headline value.

Key entities

  • issuer
    Oklo Inc.

    Subject of the Form 4 insider transaction disclosure.

  • insider
    Caroline Cochran

    Co-Founder and COO who sold shares via an open-market transaction under a 10b5-1 plan.

Read at source← All news

Related articles

AUG 9
$OKLOMed

Oklo’s Groves Research Reactor Achieves First Criticality

Oklo (NYSE: OKLO) said its Groves Isotope Test Reactor reached first criticality on private land, supported by DOE Reactor Pilot Program authorization. Los Alamos’ ZiaCore microreactor also achieved zero-power criticality. ARC Clean Technology (ARC) outlined plans for ARC-100 at INL and a term sheet for Turkey. Holtec, Entergy and Hyundai will evaluate SMR-300 projects in Gulf states.

neutronbytes.com6 min
AUG 7
$OKLOMed

Oklo Inc. Q2 2026 Earnings Call Summary

Oklo Inc. reported progress from its Q2 2026 earnings call, including first criticality at the Groves isotope facility and plans for Aurora deployments at INL and an Ohio clean energy campus. The company targeted 2028 commercial startup, expected first isotope revenue in early 2027, and raised 2026 operating cash use guidance to $120M-$150M and PP&E spend to $400M-$500M.

yahoo.com10 min
AUG 7
$OKLOMed

Oklo Stock Attempts a Turnaround, but Technical Barriers Remain as It Releases Q2 2026 Financial Results

Oklo reported Q2 2026 revenue of $1.2 million, above analysts’ ~$83,800 estimate, but posted a $0.28 per-share loss versus a ~$0.16 consensus. Net loss widened to $48.5 million from $24.7 million a year earlier. The company ended the quarter with about $3 billion in cash and marketable securities and said its Groves Isotope Test Reactor achieved first criticality.

fxleaders.com6 min
AUG 7
$OKLOMedAI 8/10

Oklo reports $1.21M Q2 revenue, $1.6B cash as Aurora milestones advance

Oklo Inc. (NYSE: OKLO) reported Q2 2026 revenue of $1.21M versus a $126,250 analyst estimate and an EPS loss of $(0.28) versus an estimated $(0.16). The company said it ended the quarter with $1.6B cash and expects 2026 operating cash flow of $120M to $150M and capex of $400M to $500M. It also advanced Aurora regulatory steps and said its Groves reactor reached first criticality.

scanx.trade7 min